Literature DB >> 2957590

Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.

J M McLenachan, E Henderson, K I Morris, H J Dargie.   

Abstract

In patients with hypertension, a pattern of left ventricular hypertrophy on the electrocardiogram is associated with a risk of sudden death in excess of the risk attributable to hypertension alone. We therefore investigated the frequency of complex ventricular arrhythmias by means of 48-hour ambulatory electrocardiographic monitoring in 100 treated hypertensive patients, of whom 50 had electrocardiographic evidence of left ventricular hypertrophy and 50 did not, and in 50 normotensive controls. The groups were matched for age, sex, and smoking habits, and the two hypertensive groups were matched for blood-pressure levels before and after antihypertensive therapy. Nonsustained ventricular tachycardia, defined as greater than or equal to 3 complexes at a rate greater than or equal to 120 beats per minute, occurred in 14 (28 percent) of the 50 patients with an electrocardiographic pattern of left ventricular hypertrophy, in 4 (8 percent) of the 50 patients without hypertrophy (P less than 0.05), and in 1 (2 percent) of the control subjects. Eight of the 50 patients (16 percent) with hypertrophy had episodes of nonsustained ventricular tachycardia longer than 5 complexes, whereas no patients without hypertrophy and no controls had such episodes. The group with nonsustained ventricular tachycardia was characterized by a high left ventricular mass on echocardiography and a high prevalence of ST-T abnormalities on electrocardiography. Ventricular tachycardia was not closely related to blood-pressure levels, nor was it associated with diuretic therapy or hypokalemia. The clinical importance of these arrhythmias is uncertain. Nevertheless, our data suggest that complex ventricular arrhythmias occur commonly in hypertensive patients with left ventricular hypertrophy and may contribute to the higher incidence of sudden death in these patients.

Entities:  

Mesh:

Year:  1987        PMID: 2957590     DOI: 10.1056/NEJM198709243171302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  91 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Echocardiographic quantification of left ventricular mass: prognostic implications.

Authors:  Rajiv S Swamy; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

3.  QT dispersion in adult hypertensives.

Authors:  Isa Muhammad Sani; Danbauchi Sulei Solomon; Oyati Albert Imhogene; Alhassan Muhammad Ahmad; Garko Sani Bala
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

Review 4.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

5.  The Romhilt-Estes electrocardiographic score predicts sudden cardiac arrest independent of left ventricular mass and ejection fraction.

Authors:  Navid Darouian; Aapo L Aro; Kumar Narayanan; Audrey Uy-Evanado; Carmen Rusinaru; Kyndaron Reinier; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-03       Impact factor: 1.468

6.  Hypertension control is needed in elderly marathon runners!

Authors:  Arnoud van der Laarse; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

7.  Susceptibility to Cardiac Arrhythmias and Sympathetic Nerve Growth in VEGF-B Overexpressing Myocardium.

Authors:  Johanna Lähteenvuo; Olli-Pekka Hätinen; Antti Kuivanen; Jenni Huusko; Jussi Paananen; Markku Lähteenvuo; Jussi Nurro; Marja Hedman; Juha Hartikainen; Nihay Laham-Karam; Petri Mäkinen; Markus Räsänen; Kari Alitalo; Anthony Rosenzweig; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2020-03-19       Impact factor: 11.454

Review 8.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

Review 9.  Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test?

Authors:  Steven M Stevens; Kyndaron Reinier; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02

10.  Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy.

Authors:  Chin-Yu Lin; Fa-Po Chung; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Korean Circ J       Date:  2015-11-25       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.